Extended antiplatelet therapy: more bleeding reported, but mortality statistics conflict
A pooled review compared extended dual therapy with single therapy after coronary intervention. It reported more bleeding, while conflicting mortality statistics limit confidence in that result.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review linked extended dual antiplatelet therapy to more bleeding and higher odds of death from any cause after coronary intervention. However, the abstract contains conflicting statements about uncertainty around mortality. Several cardiovascular outcomes showed no statistically clear difference. Because the analysis combines randomized and observational evidence, the pooled associations alone cannot establish causation.
This explanation uses the abstract alone. It cannot resolve the mortality reporting discrepancy, and follow-up durations and detailed regimens are missing. Study-level regression also cannot establish which patients would benefit from extended therapy.
What researchers found
Major bleeding
Extended dual versus single antiplatelet therapy after coronary intervention. Follow-up: Not reported in the abstract.
Different outcomes, different findings
The authors reported more major and minor bleeding with extended dual therapy. They found no statistically significant differences in heart attack, stroke, stent thrombosis, or cardiac death; that does not establish equivalent outcomes.
Why mortality remains uncertain
The abstract gives conflicting accounts of how certain the mortality result is: its uncertainty interval and probability of harm do not agree. A reliable interpretation of the numerical mortality estimate needs clarification beyond this abstract.
The original publication
Extended Dual Versus Single Anti-Platelet Therapy Following Percutaneous Coronary Intervention: A Bayesian Meta-Analysis and Regression on All-Cause Mortality.
Ahmed F, Haider F, Ali R et al.
Catheter Cardiovasc Interv · 2026
- PubMed ID
- 41298273
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.